Press Releases
Amgen commences strategic collaboration with BeiGene to expand oncology presence in China
Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world's second-largest pharmaceutical market. BeiGene is a commercial-stage research-based...
Clinical Trials
ideaPoint Partners with SAS to Provide Leading Data Sharing Solution Through ClinicalStudyDataRequest.com
Anaqua’s ideaPoint, a leading provider of innovation management solutions, has announced a partnership with SAS, the world leader in analytics. The partnership will provide to pharmaceutical companies and academic researchers the most robust clinical trial data sharing solution, with...
Drug Research
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics
Velabs Therapeutics GmbH, a biotech company focused on the rapid screening of functional therapeutic antibodies announced that it has entered into an exclusive licence agreement with alytas therapeutics GmbH , for the development and commercialization of alytas’ antibodies in...
Drug Research
Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets
Arena Pharmaceuticals, Inc. and Beacon Discovery announced that they entered into a strategic multi-year partnership (Project Cabrillo) aimed at building novel medicines across a range of G protein-coupled receptor (GPCR) targets.
Under the terms of the deal, Beacon will be...
IT & Data Management
Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson
a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, announced that it has entered into a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson*. Through the agreement, the Lung...
Drug Research
Vaccitech partners with CRUK on NSCLC immunotherapeutic vaccine
Vaccitech has signed a partnership with Cancer Research UK (CRUK) to clinically advance VTP-600, the former’s immunotherapy vaccine candidate, for patients with non-small cell lung cancer (NSCLC).
According to the terms of the agreement, CRUK’s Centre for Drug Development will...
Press Releases
Clinerion and Pangaea partner to improve cancer patient lives
Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Pangaea, a machine learning company, partner to improve faster identification of patient cohorts based on phenotypes from electronic health record (EHR)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read